Choreo LLC’s Amgen AMGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $6.96M | Buy |
19,788
+509
| +3% | +$181K | 0.09% | 178 |
|
|
2025
Q4 | $6.34M | Buy |
19,279
+779
| +4% | +$247K | 0.08% | 169 |
|
|
2025
Q3 | $5.22M | Buy |
18,500
+44
| +0.2% | +$12.8K | 0.07% | 198 |
|
|
2025
Q2 | $5.15M | Buy |
18,456
+250
| +1% | +$70.8K | 0.07% | 188 |
|
|
2025
Q1 | $5.67M | Sell |
18,206
-842
| -4% | -$249K | 0.09% | 161 |
|
|
2024
Q4 | $4.94M | Buy |
19,048
+1,369
| +8% | +$406K | 0.07% | 191 |
|
|
2024
Q3 | $5.66M | Buy |
17,679
+1,615
| +10% | +$528K | 0.08% | 171 |
|
|
2024
Q2 | $5M | Buy |
16,064
+12,079
| +303% | +$3.55M | 0.08% | 161 |
|
|
2024
Q1 | $1.13M | Buy |
3,985
+134
| +3% | +$39.2K | 0.03% | 247 |
|
|
2023
Q4 | $1.11M | Buy |
3,851
+180
| +5% | +$49K | 0.03% | 243 |
|
|
2023
Q3 | $987K | Buy |
3,671
+80
| +2% | +$20K | 0.03% | 197 |
|
|
2023
Q2 | $797K | Buy |
3,591
+28
| +0.8% | +$6.5K | 0.03% | 228 |
|
|
2023
Q1 | $861K | Buy |
3,563
+280
| +9% | +$68.7K | 0.03% | 222 |
|
|
2022
Q4 | $862K | Buy |
3,283
+4
| +0.1% | +$1.07K | 0.04% | 108 |
|
|
2022
Q3 | $739K | Sell |
3,279
-4
| -0.1% | -$970 | 0.04% | 106 |
|
|
2022
Q2 | $799K | Buy |
3,283
+62
| +2% | +$15.2K | 0.04% | 104 |
|
|
2022
Q1 | $779K | Hold |
3,221
| – | – | 0.04% | 117 |
|
|
2021
Q4 | $725K | Sell |
3,221
-172
| -5% | -$36.3K | 0.04% | 120 |
|
|
2021
Q3 | $721K | Buy |
3,393
+63
| +2% | +$14.5K | 0.04% | 117 |
|
|
2021
Q2 | $812K | Buy |
3,330
+1,969
| +145% | +$484K | 0.04% | 106 |
|
|
2021
Q1 | $339K | Buy |
1,361
+20
| +1% | +$4.77K | 0.02% | 147 |
|
|
2020
Q4 | $308K | Sell |
1,341
-308
| -19% | -$71K | 0.02% | 154 |
|
|
2020
Q3 | $419K | Buy |
1,649
+625
| +61% | +$155K | 0.04% | 130 |
|
|
2020
Q2 | $242K | Sell |
1,024
-116
| -10% | -$26.5K | 0.02% | 159 |
|
|
2020
Q1 | $231K | Sell |
1,140
-293
| -20% | -$64K | 0.03% | 155 |
|
|
2019
Q4 | $346K | Sell |
1,433
-64
| -4% | -$14.1K | 0.03% | 146 |
|
|
2019
Q3 | $290K | Sell |
1,497
-1,061
| -41% | -$204K | 0.03% | 150 |
|
|
2019
Q2 | $471K | Sell |
2,558
-200
| -7% | -$35.8K | 0.06% | 119 |
|
|
2019
Q1 | $524K | Buy |
2,758
+713
| +35% | +$136K | 0.06% | 109 |
|
|
2018
Q4 | $398K | Buy |
2,045
+136
| +7% | +$26.5K | 0.06% | 117 |
|
|
2018
Q3 | $396K | Sell |
1,909
-1,971
| -51% | -$388K | 0.05% | 142 |
|
|
2018
Q2 | $716K | Sell |
3,880
-418
| -10% | -$73.9K | 0.1% | 107 |
|
|
2018
Q1 | $733K | Sell |
4,298
-297
| -6% | -$54.5K | 0.09% | 121 |
|
|
2017
Q4 | $799K | Buy |
4,595
+1,465
| +47% | +$259K | 0.1% | 104 |
|
|
2017
Q3 | $584K | Buy |
3,130
+609
| +24% | +$108K | 0.08% | 134 |
|
|
2017
Q2 | $434K | Sell |
2,521
-707
| -22% | -$115K | 0.06% | 161 |
|
|
2017
Q1 | $530K | Sell |
3,228
-40
| -1% | -$6.65K | 0.08% | 132 |
|
|
2016
Q4 | $478K | Buy |
3,268
+13
| +0.4% | +$1.96K | 0.08% | 137 |
|
|
2016
Q3 | $543K | Buy |
3,255
+491
| +18% | +$83K | 0.09% | 111 |
|
|
2016
Q2 | $421K | Buy |
2,764
+600
| +28% | +$93.3K | 0.08% | 120 |
|
|
2016
Q1 | $325K | Buy |
2,164
+363
| +20% | +$53.9K | 0.07% | 136 |
|
|
2015
Q4 | $292K | Sell |
1,801
-116
| -6% | -$18.2K | 0.07% | 120 |
|
|
2015
Q3 | $265K | Buy |
1,917
+253
| +15% | +$39.9K | 0.07% | 117 |
|
|
2015
Q2 | $255K | Buy |
1,664
+201
| +14% | +$32.2K | 0.06% | 122 |
|
|
2015
Q1 | $234K | Buy |
1,463
+38
| +3% | +$5.99K | 0.06% | 131 |
|
|
2014
Q4 | $227K | Sell |
1,425
-125
| -8% | -$19.5K | 0.06% | 133 |
|
|
2014
Q3 | $218K | Buy |
+1,550
| New | +$202K | 0.06% | 137 |
|
|
2014
Q2 | – | Sell |
-2,022
| Closed | -$249K | – | 147 |
|
|
2014
Q1 | $249K | Buy |
+2,022
| New | +$245K | 0.07% | 117 |
|
Other funds holding AMGN
VCM
VPM
Choreo LLC's AMGN Position: Q1 2026 in Review
Choreo LLC increased its Amgen (AMGN) stake by 2.6% in Q1 2026, buying an estimated $181K and bringing the position to 19,788 shares worth $6.96M. The position accounts for 0.09% of the portfolio, ranked #178.
Choreo LLC first reported a position in AMGN in Q1 2014 and has held it in 48 quarters since. 3,129 funds tracked by Wall St. Rank hold AMGN as of Q1 2026.
- Choreo LLC held 19,788 shares of Amgen worth $6.96M as of Q1 2026.
- Choreo LLC bought 509 Amgen shares in Q1 2026, an estimated $181K.
- Amgen made up 0.09% of Choreo LLC's portfolio in Q1 2026, its #178 holding.
- Choreo LLC first reported a position in Amgen in Q1 2014 and has held it in 48 quarters since.
- 3,129 funds tracked by Wall St. Rank held Amgen as of Q1 2026.
Based on Choreo LLC's 13F filing for Q1 2026, filed 13 May 2026.